Effects of SAHA and EGCG on Growth Potentiation of Triple-Negative Breast Cancer Cells

FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration

(2018) Ella Fung et al.   EMBO REPORTS

Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands

(2018) Lara N. Gechijian et al.   Nature Chemical Biology

SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma

(2018) Masum Saini et al.   Cell Death & Disease

Cellular inhibitor of apoptosis protein 2 promotes the epithelial-mesenchymal transition in triple-negative breast cancer cells through activation of the AKT signaling pathway

(2017) Su Ji Jo et al.   Oncotarget

Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression

(2017) Yuanyuan Li et al.   Scientific Reports

Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer Cells

(2017) Aneta Grabarska et al.   Journal of Cancer

Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases

(2017) Jialin Song et al.   Frontiers in Immunology

Diet, Nutrition, and Cancer Epigenetics

(2016) Carmen Sapienza et al.   Annual Review of Nutrition

miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway

(2016) Bailong Li et al.   BIOMEDICINE & PHARMACOTHERAPY

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

(2016) Giampaolo Bianchini et al.   Nature Reviews Clinical Oncology

Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer

(2016) Li Ma et al.   TUMOR BIOLOGY

The association of PTEN hypermethylation and breast cancer: a meta-analysis

(2016) Shanshan Luo et al.   OncoTargets and Therapy

Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells

(2015) Panagiotis Bouris et al.   MATRIX BIOLOGY

Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery

(2015) Yanai Zhan et al.   Epigenetics & Chromatin

Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value

(2015) Clare Stirzaker et al.   Nature Communications

TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway

(2014) L-H Zhang et al.   ONCOGENE

Basal-Like and Triple-Negative Breast Cancers

(2014) Prasanna Alluri et al.   Surgical Oncology Clinics of North America

Mechanism of miRNA-mediated repression of mRNA translation

(2013) Tamas Dalmay   Essays in Biochemistry

miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer

(2013) Michael S. Hwang et al.   PLoS One

PTEN mutation, methylation and expression in breast cancer patients

(2013) HONG-YAN ZHANG et al.   Oncology Letters

A Novel Prodrug of Epigallocatechin-3-gallate: Differential Epigenetic hTERT Repression in Human Breast Cancer Cells

(2011) S. M. Meeran et al.   Cancer Prevention Research

miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy

(2011) M. Garofalo et al.   CURRENT MOLECULAR MEDICINE

miR-221/222 Targeting of Trichorhinophalangeal 1 (TRPS1) Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer

(2011) S. Stinson et al.   Science Signaling

MicroRNA Cluster 221-222 and Estrogen Receptor α Interactions in Breast Cancer

(2010) Gianpiero Di Leva et al.   JNCI-Journal of the National Cancer Institute

Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells

(2010) Yuanyuan Li et al.   Molecular Cancer

TRIM24 links a non-canonical histone signature to breast cancer

(2010) Wen-Wei Tsai et al.   NATURE

A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study

(2008) T. H. Luu et al.   CLINICAL CANCER RESEARCH

Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells

(2008) Q. Zhou et al.   MOLECULAR CANCER RESEARCH

Reversal of hypermethylation and reactivation of genes by dietary polyphenolic compounds

(2008) Chung S Yang et al.   NUTRITION REVIEWS

Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG

(2007) Joel B. Berletch et al.   JOURNAL OF CELLULAR BIOCHEMISTRY